Angel Galindo, correspondant of the “The Pharmaletter”, highlights FIFARMA’s participation in ISPOR Latin America 2019 in his article “MEAs, sustainability and promoting vaccines: evidence of the need for collaboration in Latin American healthcare”. The article mentions the main conclusions of the educational symposium held by FIFARMA on Managed Entry Agreements (MEAs) moderated by Rafael Andrés Díaz-Granados, Executive Director of FIFARMA and with Héctor Castro, Louis Garrison, Jens Grueger acting as panelists. “During the dialogue, the importance of promoting communication between stakeholders, learning from the experiences of other countries and building trust and transparency between different actors in the pharmaceutical industry was highlighted, as this is essential for successful MEAs in the region” *
The article also highlights the award obtained by FIFARMA for the best podium presentation with document: “The proposed solutions to achieve sustainability in Latin America” developed jointly with CB Partners and presented by Diego Guarin, Co-Chair of FIFARMA’s Value and Access to Innovation group.
In conclusion, it mentions the importance of all actors from the healthcare system working together to develop sustainable healthcare systems in the region that always have patients’ benefit at their central axis.
* From article “MEAs, sustainability and promoting vaccines: evidence of the need for collaboration in Latin American healthcare”
To read the article in The Pharma Letter you can visit: http://bit.ly/2IChtvM